| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.3M | +9.1% |
| Cost of Revenue | $7.3M | -35.3% |
| Gross Profit | -$1.1M | +81.0% |
| R&D Expense | $12.6M | +31.2% |
| SG&A Expense | $11.6M | -32.5% |
| Operating Income | -$32.5M | +56.1% |
| Pre-tax Income | -$32.3M | +56.1% |
| Income Tax | $0 | — |
| Net Income | -$32.3M | +56.1% |
| EPS (Basic) | -$0.42 | +61.1% |
| EPS (Diluted) | -$0.42 | +61.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.2M | +16.3% |
| Accounts Receivable | $1.6M | +1.1% |
| Inventory | $2.2M | -54.5% |
| Current Assets | $27.2M | +1.8% |
| Total Assets | $40.1M | +1.7% |
| Current Liabilities | $4.9M | +131.4% |
| Total Liabilities | $5.4M | +155.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.8M | +20.9% |
| Capital Expenditures | $2.0M | +48.2% |
| Investing Cash Flow | -$2.6M | +10.3% |
| Financing Cash Flow | $24.4M | +33.2% |
| Free Cash Flow | -$20.8M | +17.1% |
| $24.7M |
| -33.8% |